Büşra Kaplan (Busra Kaplan)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 4

Top Topics

Inflammatory Response

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Zafer Sezer, Shaikh Terkis Islam Pavel, Ahmet Inal, Hazel Yetiskin, Büşra Kaplan, Muhammet Ali Uygut, Ahmet Furkan Aslan, Adnan Bayram, Mümtaz M Mazicioglu, Gamze Kalin Unuvar, Zeynep Ture Yuce, Gunsu Aydin, Refika Kamuran Kaya, Ihsan Ates, Ateş Kara, Aykut Ozdarendeli
Long-Term Immunogenicity and Safety of a Homologous Third Dose Booster Vaccination with TURKOVAC: Phase 2 Clinical Study Findings with 32-Week Post-Booster Follow-Up. Vaccines 12 (2) (2024)
Zafer Sezer, Shaikh Terkis Islam Pavel, Ahmet Inal, Hazel Yetiskin, Büşra Kaplan, Muhammet Ali Uygut, Ahmet Furkan Aslan, Adnan Bayram, Mümtaz M Mazicioglu, Gamze Kalin Unuvar, Zeynep Ture Yuce, Gunsu Aydin, Refika Kamuran Kaya, Ihsan Ates, Ateş Kara, Aykut Ozdarendeli
Long-Term Immunogenicity and Safety of a Homologous Third Dose Booster Vaccination with TURKOVAC: Phase 2 Clinical Study Findings with 32-Week Post-Booster Follow-Up. Vaccines 12 (2) (2024)
Shaikh Terkis Islam Pavel, Hazel Yetiskin, Muhammet Ali Uygut, Ahmet Furkan Aslan, Günsu Aydın, Öznur İnan, Büşra Kaplan, Aykut Ozdarendeli
Development of an Inactivated Vaccine against SARS CoV-2. Vaccines 9 (11) (2021)
Tarlan Mamedov, Damla Yuksel, Merve Ilgın, Irem Gürbüzaslan, Burcu Gulec, Gulshan Mammadova, Aykut Ozdarendeli, Hazel Yetiskin, Büşra Kaplan, Shaikh Terkis Islam Pavel, Muhammet Ali Uygut, Gulnara Hasanova
Production and Characterization of Nucleocapsid and RBD Cocktail Antigens of SARS-CoV-2 in Nicotiana benthamiana Plant as a Vaccine Candidate against COVID-19. Vaccines 9 (11) (2021)